BLRX

BioLineRX
BLRX

Overview Fund Activity

34 hedge funds and large institutions have $15.7M invested in BioLineRX in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+8
Holders Change %
+30.77%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EMG
1
ETF Managers Group
New Jersey
$164K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$54K
3
MC
3
Menta Capital
California
$33K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$27K
5
Citadel Advisors
5
Citadel Advisors
Florida
$26K

Top Sellers

1
SM
1
Senvest Management
New York
$2.11M
2
CS
2
Credit Suisse
Switzerland
$0
3
NFG
3
Next Financial Group
Texas
$17K
4
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$9K
5
MCC
5
Malaga Cove Capital
California
$11K
Name Holding Trade Value Shares
Change 		Shares
Change %
LPL Financial
26
LPL Financial
California
$6K +$6K +22 New
Creative Planning
27
Creative Planning
Kansas
$4K – – –
UBS Group
28
UBS Group
Switzerland
$4K +$4K +17 New
PVH
29
Psagot Value Holdings
Israel
$3K +$818 +3 +38%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$1K – – –
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$1K – – –
RE
32
RBC Europe
United Kingdom
$87 -$214 – –
CS
33
Credit Suisse
Switzerland
– -$33K -51 Closed
1
2